Mold-Rite Plastics to be Acquired by IPC

Irving Place Capital (“IPC”), a middle-market private equity firm, today announced that it has signed a purchase agreement to acquire Mold-Rite Plastics, Inc. (“Mold-Rite” or the “Company”), a leading manufacturer of plastic caps, child-resistant closures, vials, and jars primarily serving the pharmaceutical, nutraceutical, and personal care markets. The transaction is expected to close within 60 days.

Upon completion of the transaction, Phil Yates will join Mold-Rite as Executive Chairman, working closely with the existing management team in realizing the Company’s growth objectives. Mr. Yates, who currently serves as a Senior Advisor to IPC, brings to Mold-Rite over 35 years of industry experience and a broad industry network. He previously held the position of Chairman and CEO of Graham Packaging, a global leader in rigid plastic packaging. During his tenure at Graham, Yates drove sales from $500 million to $2.5 billion and was responsible for initiating industry-wide advancements through the development of new packaging technologies.

“Mold-Rite is a highly successful business in one of the most attractive sectors of the packaging industry,” said Mr. Yates. “The Company has substantial growth potential and I am confident that with IPC’s deep industry knowledge and significant resources, we will be able to quickly execute a number of initiatives to further support the needs of our customers.”

“The acquisition of Mold-Rite is an exciting development for IPC’s packaging effort,” said Phil Carpenter, a Senior Managing Director at IPC. “We have been actively looking to invest in the caps and closures segment for some time and Mold-Rite is an exceptional platform. We look forward to our partnership with Mold-Rite’s management team and are very focused on realizing the Company’s tremendous potential.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.